Abstract
Axicabtagene Ciloleucel Compared to Tisagenlecleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma in the Real World Setting in Spain
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have